Showing results (1491-1500 of 1,640) with videos related to

Sort By:
Pageof 164
Journal of Medicinal Chemistry|June 27, 2018
Identification of Morpholino Thiophenes as Novel Mycobacterium tuberculosis Inhibitors, Targeting QcrBLaura A T Cleghorn, Peter C Ray, Joshua Odingo, et al.
Biomolecules|March 28, 2024
Vascular Calcification: Molecular Networking, Pathological Implications and Translational OpportunitiesMiguel A Ortega, Diego De Leon-Oliva, Maria José Gimeno-Longas, et al.
Toxicon : Official Journal of the International Society on Toxinology|January 17, 2018
Calcium-dependent disorder-to-order transitions are central to the secretion and folding of the CyaA toxin of Bordetella pertussis, the causative agent of whooping coughDarragh P O'Brien, Ana Cristina Sotomayor Perez, Johanna Karst, et al.
Journal of Synchrotron Radiation|March 7, 2022
ID23-2: an automated and high-performance microfocus beamline for macromolecular crystallography at the ESRFMax Nanao, Shibom Basu, Ulrich Zander, et al.
Journal of Synchrotron Radiation|July 7, 2018
ID30B - a versatile beamline for macromolecular crystallography experiments at the ESRFAndrew A McCarthy, Ray Barrett, Antonia Beteva, et al.
Gastroenterology|October 9, 2012
Inactivation of Patched1 in mice leads to development of gastrointestinal stromal-like tumors that express Pdgfrα but not kitPenelope Pelczar, Arne Zibat, Willemijn A van Dop, et al.
Revista Clinica Espanola|June 11, 2023
Consensus document for lipid profile testing and reporting in Spanish clinical laboratories: What parameters should a basic lipid profile include?Teresa Arrobas Velilla, Carlos Guijarro, Raquel Campuzano Ruiz, et al.
Journal of Synchrotron Radiation|May 5, 2022
ID23-2: an automated and high-performance microfocus beamline for macromolecular crystallography at the ESRF. CorrigendumMax Nanao, Shibom Basu, Ulrich Zander, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 7, 2013
Proteasome activator complex PA28 identified as an accessible target in prostate cancer by in vivo selection of human antibodiesDavid Sánchez-Martín, Jorge Martínez-Torrecuadrada, Tambet Teesalu, et al.
Pageof 164